Works matching AU Udagawa, Hibiki


Results: 22
    1
    2
    3
    4
    5
    6
    7
    8

    Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 8, p. 1417, doi. 10.1007/s00432-015-1912-7
    By:
    • Udagawa, Hibiki;
    • Ishii, Genichiro;
    • Morise, Masahiro;
    • Umemura, Shigeki;
    • Matsumoto, Shingo;
    • Yoh, Kiyotaka;
    • Niho, Seiji;
    • Ohmatsu, Hironobu;
    • Tsuboi, Masahiro;
    • Goto, Koichi;
    • Ochiai, Atsushi;
    • Ohe, Yuichiro
    Publication type:
    Article
    9

    Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2205, doi. 10.1007/s00262-023-03393-8
    By:
    • Tanaka, Yu;
    • Nakai, Tokiko;
    • Suzuki, Ayako;
    • Kagawa, Yosuke;
    • Noritake, Osamu;
    • Taki, Tetsuro;
    • Hashimoto, Hiroko;
    • Sakai, Tetsuya;
    • Shibata, Yuji;
    • Izumi, Hiroki;
    • Nosaki, Kaname;
    • Udagawa, Hibiki;
    • Zenke, Yoshitaka;
    • Matsumoto, Shingo;
    • Yoh, Kiyotaka;
    • Miyazaki, Saori;
    • Sakamoto, Naoya;
    • Sakashita, Shingo;
    • Kojima, Motohiro;
    • Watanbe, Reiko
    Publication type:
    Article
    10
    11
    12

    Prognostic impact and gene expression analysis of peri‐tumoral alveolar macrophage in resected lung adenocarcinoma.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3423, doi. 10.1111/cas.15848
    By:
    • Kagawa, Yosuke;
    • Nakai, Tokiko;
    • Taki, Tetsuro;
    • Hashimoto, Hiroko;
    • Tanaka, Yu;
    • Sakai, Tetsuya;
    • Shibata, Yuji;
    • Izumi, Hiroki;
    • Nosaki, Kaname;
    • Udagawa, Hibiki;
    • Zenke, Yoshitaka;
    • Matsumoto, Shingo;
    • Yoh, Kiyotaka;
    • Miyazaki, Saori;
    • Watanabe, Reiko;
    • Kojima, Motohiro;
    • Sakashita, Shingo;
    • Sakamoto, Naoya;
    • Tsuboi, Masahiro;
    • Goto, Koichi
    Publication type:
    Article
    13

    Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816
    By:
    • Sugawara, Shunichi;
    • Tanaka, Kentaro;
    • Imamura, Fumio;
    • Yamamoto, Nobuyuki;
    • Nishio, Makoto;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Tanaka, Hiroshi;
    • Fukuhara, Tatsuro;
    • Nakahara, Yasuharu;
    • Kurata, Takayasu;
    • Katakami, Nobuyuki;
    • Okada, Morihito;
    • Horinouchi, Hidehito;
    • Udagawa, Hibiki;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Saka, Hideo;
    • Tokito, Takaaki;
    • Hosomi, Yukio
    Publication type:
    Article
    14

    Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy.

    Published in:
    Cancer Science, 2023, v. 114, n. 2, p. 630, doi. 10.1111/cas.15621
    By:
    • Noda‐Narita, Shoko;
    • Naito, Tomoyuki;
    • Udagawa, Hibiki;
    • Goto, Koichi;
    • Miyawaki, Taichi;
    • Mamesaya, Nobuaki;
    • Nakashima, Kazuhisa;
    • Kenmotsu, Hirotsugu;
    • Shimokawaji, Tadasuke;
    • Kato, Terufumi;
    • Hakozaki, Taiki;
    • Okuma, Yusuke;
    • Nakamura, Masaki;
    • Nakayama, Yuko;
    • Watanabe, Hirokazu;
    • Kusumoto, Masahiko;
    • Ohe, Yuichiro;
    • Horinouchi, Hidehito
    Publication type:
    Article
    15
    16
    17

    CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.

    Published in:
    Scientific Reports, 2017, p. 46662, doi. 10.1038/srep46662
    By:
    • Ishibashi, Masayuki;
    • Neri, Shinya;
    • Hashimoto, Hiroko;
    • Miyashita, Tomoyuki;
    • Yoshida, Tatsuya;
    • Nakamura, Yuka;
    • Udagawa, Hibiki;
    • Kirita, Keisuke;
    • Matsumoto, Shingo;
    • Umemura, Shigeki;
    • Yoh, Kiyotaka;
    • Niho, Seiji;
    • Tsuboi, Masahiro;
    • Masutomi, Kenkichi;
    • Goto, Koichi;
    • Ochiai, Atsushi;
    • Ishii, Genichiro
    Publication type:
    Article
    18

    LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion.

    Published in:
    Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06116-6
    By:
    • Mori, Shunta;
    • Izumi, Hiroki;
    • Araki, Mitsugu;
    • Liu, Jie;
    • Tanaka, Yu;
    • Kagawa, Yosuke;
    • Sagae, Yukari;
    • Ma, Biao;
    • Isaka, Yuta;
    • Sasakura, Yoko;
    • Kumagai, Shogo;
    • Sakae, Yuta;
    • Tanaka, Kosuke;
    • Shibata, Yuji;
    • Udagawa, Hibiki;
    • Matsumoto, Shingo;
    • Yoh, Kiyotaka;
    • Okuno, Yasushi;
    • Goto, Koichi;
    • Kobayashi, Susumu S.
    Publication type:
    Article
    19
    20
    21

    Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.

    Published in:
    Thoracic Cancer, 2021, v. 12, n. 13, p. 1983, doi. 10.1111/1759-7714.14001
    By:
    • Miura, Kaho;
    • Sano, Yoshiyuki;
    • Niho, Seiji;
    • Kawasumi, Kenji;
    • Mochizuki, Nobuo;
    • Yoh, Kiyotaka;
    • Matsumoto, Shingo;
    • Zenke, Yoshitaka;
    • Ikeda, Takaya;
    • Nosaki, Kaname;
    • Kirita, Keisuke;
    • Udagawa, Hibiki;
    • Goto, Koichi;
    • Kawasaki, Toshikatsu;
    • Hanada, Kazuhiko
    Publication type:
    Article
    22